Kay, Lara <br/><br/>
Eslicarbazepine acetate as a therapeutic option in a patient with carbamazepine-induced rash and HLA-A*31:01.  [electronic resource] 

 -  Seizure  Apr 2017 
 - 81-82 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1532-2688 
<br/><br/><label>Standard No.: </label>10.1016/j.seizure.2017.02.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anticonvulsants--adverse effects<br/>Carbamazepine--adverse effects<br/>Dibenzazepines--therapeutic use<br/>Epilepsy, Frontal Lobe--drug therapy<br/>Exanthema--etiology<br/>Female<br/>HLA-B15 Antigen--genetics<br/>Haplotypes<br/>Humans<br/>Pharmacogenomic Variants<br/>Voltage-Gated Sodium Channel Blockers--therapeutic use